{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:59:14Z","timestamp":1783522754322,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctrv.2026.103142","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:55:31Z","timestamp":1777161331000},"page":"103142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of infections in the outpatient care of patients with cancer"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-6656","authenticated-orcid":false,"given":"Michael","family":"Sandherr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4334-3403","authenticated-orcid":false,"given":"Christina","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2026.103142_b0005","unstructured":"NCCN Guidelines Version 1.2026, Prevention and Treatment of Cancer-Related Infections. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf."},{"issue":"suppl 5","key":"10.1016\/j.ctrv.2026.103142_b0010","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropenia: ESMO Clinical Practice Guideline","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103142_b0105","doi-asserted-by":"crossref","unstructured":"Bergeron A, Mikulska M, De Greef J et al. Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Lancet Infect Dis 2022;22:e359-e369. doi: 10.1016\/S1473-3099(22)00227-4.","DOI":"10.1016\/S1473-3099(22)00227-4"},{"key":"10.1016\/j.ctrv.2026.103142_b0110","doi-asserted-by":"crossref","unstructured":"Maschmeyer G, De Greef J, Mellinghoff SC et al. Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia 2019;33:844-862. doi: 10.1038\/s41375-019-0388-x.","DOI":"10.1038\/s41375-019-0388-x"},{"key":"10.1016\/j.ctrv.2026.103142_b0115","doi-asserted-by":"crossref","unstructured":"Pagano L, Maschmeyer G, Lamoth F et al. Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2025 Jul;39(7):1547-1557. doi:10.1038\/s41375-025-02586-7.","DOI":"10.1038\/s41375-025-02586-7"},{"issue":"Suppl 1","key":"10.1016\/j.ctrv.2026.103142_b0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ctrv.2026.103142_b0035","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"Classen","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctrv.2026.103142_b0040","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1(1):CD004386","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103142_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103142_b0050","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoetic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"issue":"Suppl 7","key":"10.1016\/j.ctrv.2026.103142_b0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imj.70250","article-title":"Consensus guidelines for antibacterial prophylaxis in patients with neutropenia","volume":"55","author":"Lindsay","year":"2025","journal-title":"Intern Med J"},{"key":"10.1016\/j.ctrv.2026.103142_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaip.2013.11.002","article-title":"Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction","volume":"2","author":"Pyle","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"94","key":"10.1016\/j.ctrv.2026.103142_b0060","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","article-title":"Antiviral prophylaxis in patients with solid tumors and hematological malignancies\u2014update of the guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)","volume":"2015","author":"Sandherr","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctrv.2026.103142_b0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00277-021-04746-y","volume":"101","author":"Henze","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctrv.2026.103142_b0070","unstructured":"ONKOPEDIA. Infections in the outpatient setting (in German). 11\/2015. https:\/\/www.onkopedia.com\/de\/onkopedia\/guidelines\/infektionen-in-der-ambulanz\/@@guideline\/html\/index.html."},{"key":"10.1016\/j.ctrv.2026.103142_b0075","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/annonc\/mdy117","article-title":"Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors\u2014Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)","volume":"29","author":"Rieger","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2026.103142_b0080","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S1470-2045(25)00765-X","article-title":"Anti-infective Vaccination strategies in patients with Haematological Malignancies or Solid Tumours \u2013 2025 Update of the Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"27","author":"Mellinghoff","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2026.103142_b0085","article-title":"2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumors and hematological malignancies","volume":"51","author":"Sandherr","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ctrv.2026.103142_b0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctrv.2026.103142_b0015","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2026.103142_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11654-026-00714-y","article-title":"Infections during treatment with bispecific antibodies in patients with malignant lymphoma, multiple myeloma, and acute lymphatic leukemia (in German)","volume":"21","author":"Ruckdeschel","year":"2026","journal-title":"Best Practice Onkologie"},{"key":"10.1016\/j.ctrv.2026.103142_b0025","unstructured":"ONKOPEDIA. CAR T-cells: management of adverse effects (in German) 05.2025, https:\/\/www.onkopedia.com\/s\/WIC4LR."},{"key":"10.1016\/j.ctrv.2026.103142_b0100","unstructured":"NCCN Guidelines Version 2.2026. Management of CAR T-Cell and lymphocyte engager-related toxicities. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cellular_tox.pdf."}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:06:59Z","timestamp":1778292419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"alternative-id":["S0305737226000563"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103142","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of infections in the outpatient care of patients with cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103142"}}